Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof

Crystalline freebase forms of a biphenyl compound

Compounds useful as inhibitors of ATR kinase

Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereof

Crystalline forms of a biphenyl compound

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Method For The Preparation Of Cinacalcet And Intermediates And Impurities Thereof

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

Polymorphs of darunavir

Crystalline, anhydrous forms of oxymorphone hydrochloride

Crystalline forms of a purine derivative

Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma

Crystal form of cabazitaxel and preparation method thereof

Solid forms of an antiviral compound

PREPARATION OF FEBUXOSTAT

Agomelatine sulfuric acid complex, and preparation method and application thereof

Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Multicomponent crystals comprising dasatinib and selected co-crystal formers

Atrasentan mandelate salts

Inhibitors of Bruton's tyrosine kinase

Salts

Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Crystalline forms of therapeutic compounds and uses thereof

3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof

Tranilast compositions and cocrystals

Process for making CGRP receptor antagonists

Amides of 2-amino-4-arylthiazole compounds and their salts

Crystalline forms of a dipeptidyl peptidase-IV inhibitors

Nilotinib salts and crystalline forms thereof

Processes and intermediates for producing azaindoles

Crystalline form A of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[B][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione

Solid forms of 3-(4-nitro-1-oxisoindolin-2-yl)piperidine-2,6-dione

Process for the preparation of benzimidazole derivatives and salts thereof

PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES

Polymorphic form of a long-acting beta-2 adrenoceptor agonist

Method to Produce and Scale-Up Cocrystals and Salts Via Resonant Acoustic Mixing

4-(3-benzyloxyphenylthio)-2-chloro-1-(3-nitropropyl)benzene crystal

Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof

Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use

LEVALBUTEROL SALT

Ginsenoside C-K polymorphic compounds and method for preparing same

KINASE INHIBITOR POLYMORPHS

SALTS OF 5-[(1R)-2-(AMINO)-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONE

Two crystal forms of ginsenoside C-K and method for preparing same

Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor

Valomaciclovir polymorphs

Crystalline forms of 5α-androstane-3β,5,6β-triol and preparation methods therefor

Compound, method for producing compound, and method for purifying compound

Crystalline diacylhydrazine and the use thereof

Crystalline Solid Rasagiline Base

PROCESS FOR THE PREPARATION OF CARBAPENEM ANTIBIOTIC

Solid forms of dabigatran etexilate mesylate and processes for their preparation

PROCESS FOR THE SYNTHESIS OF TELAPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

Solid state forms of cabazitaxel and processes for preparation thereof

Crystalline forms of a prolyl hydroxylase inhibitor

Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof

Crystal form of pyrrolidylthiocarbapenem derivative

Production Of Stabilized Channel Type Cyclodextrin Crystals

Crystalline ingenol mebutate

Benzimidazole compound crystal

NOVEL POLYMORPHS OF FOSAMPRENAVIR CALCIUM

Crystal form of (6S)-5-methyltetrahydrofolate salt and method for preparing same

Crystal form of prostaglandin analogue, and preparation method and use thereof

Methods of synthesizing substituted purine compounds

Kinase inhibitor polymorphs

Polymorphs of N-(2-methoxybenzoyl)-4-[(methylaminocarbonyl)amino] benzenesulfonamide

Efficient process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption

Cocrystals of dimethyl fumarate

Stable crystal modifications of DOTAP chloride

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

Benzoimidazol-2-yl pyrimidine derivatives

ALISKIREN HEMIFUMARATE, CRYSTAL FORM AND AMORPHOUS SOLID

NOVEL POLYMORPHS OF N-[2-AMINO-4-(4-FLUOROBENZYLAMINO)-PHENYL] CARBAMIC ACID ETHYL ESTER AND PROCESSES THEREOF

Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)

Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof

Liquid crystalline compound and electrolyte material

Salt of (R)-3-(6-amino-pyridin-3-yl)-2-(1-Cyclohexyl-1H-imidazol-4-yl) ethyl propionate

Crystalline form of 3-methylsulfonylpropionitrile

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

Polymorphs of CDDO ethyl ester and uses thereof

Cocrystalline DHEA formulations

Method for producing glufosinate P free acid

Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

HYDRATE AND CRYSTAL OF FLUORENE COMPOUNDS

Crystalline cis-(E)-4-(3-fluorophenyl)-2′,3′,4′,9′-tetrahydro-N,N-dimethyl-2′-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1′[1H]

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof

Devices and methods for crystallization

Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods of preparing the same and use of the same

Crystalline form of γ-aminobutyric acid analog

Cocrystals of progesterone

Method for preparing an aromatic composition including a compound containing two solids having organoleptic properties

Process for preparing high purity and crystalline dimethyl fumarate

Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide

Aniline type compounds

Use of form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

Process for the preparation of fluticasone propionate form 1

Processes for the preparation of prostaglandin amides

Tigecycline crystalline hydrate and preparation method therefor and use thereof

Process for preparing chiral dipeptidyl peptidase-IV inhibitors

Synthesis process, and crystalline form of 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it

Stable crystal modifications of DOTAP chloride

Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use

Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation

Crystalline form of carbamoyl-cyclohexane derivatives

Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size

Process for the preparation of and crystalline forms of optical enantiomers of modafinil

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

Salts and polymorphs of a tetracycline compound

Synthesis of triethylenetetramines

Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin Dand related precursors

Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D

Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3

Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D

Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid

Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs

Fingolimod polymorphs and their processes

Heterocyclic inhibitors of histamine receptors for the treatment of disease

Levalbuterol salt

Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods

Process for the preparation of Nilotinib

Processes for the preparation of fesoterodine

Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same

Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide

BNA crystal

Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol

Metal-assisted and microwave-accelerated evaporative crystallization

Solid state forms of tapentadol salts

Crystalline diacylhydrazine and the use thereof

Process for the preparation of pleuromutilins

Use of polyols to obtain stable polymorphous forms of rifaximin

Crystalline forms of a purine derivative

Noribogaine salt ansolvates

SALT OF NAPHTHYRIDINE CARBOXYLIC ACID DERIVATIVE

Salt of fused heterocyclic derivative and crystal thereof

NOVEL PIPERIDINO-DIHYDROTHIENOPYRIMIDINE SULFOXIDES AND THEIR USE FOR TREATING COPD AND ASTHMA

NOVEL CRYSTAL FORM OF PYRROLIDYLTHIOCARBAPENEM DERIVATIVE

Bupropion hydrobromide polymorphs

Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3

DP2 antagonist and uses thereof

Crystalline forms of pitavastatin calcium

Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use

Compounds

LEVALBUTEROL SALT

Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs

Polymorphs of darunavir

Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof

Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods

Crystalline forms of a macrolide, and uses therefor

INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE

CRYSTALLINE FORMS OF TIGECYCLINE HYDROCHLORIDE

Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same

Crystalline forms of neurotrophin mimetic compounds and their salts

Forms of CDDO methyl ester

NEW SALTS

Method of resolution of (RS)- 1,1′-BI-2-naphthol for obtaining enantiomeric pure I.E. (S)-(−)-1,1′-BI-2-naphthol and/or (R)-(+)-1,1′-BI-2-naphthol via co-crystal formation with optically active derivatives of γ-amino acids

Benzimidazole compound crystal

Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them

Synthesis process, and crystalline form of 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing it

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Low hygroscopic aripiprazole drug substance and processes for the preparation

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride

TREATMENT METHODS USING PHARMACEUTICAL SOLID STATE FORMS

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

Levodopa Prodrugs, and Compositions and Uses Thereof

CRYSTALLINE ANHYDRATE FORMS OF A PHARMACEUTICAL

POLYMORPHS

Processes for the preparation of ()-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof

Certain compounds, compositions and methods

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Forms of cidofovir

Crystalline form of Bimatoprost, preparation method and use thereof

Polymorphic forms of O-desmethyl-venlafaxine succinate

Forms of rifaximin and uses thereof

Process for the preparation of O-desmethyl-venlafaxine and salts thereof

Agomelatine and pharmaceutical compositions thereof

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

Process for the production of a pemetrexed salt

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester

PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR

CRYSTALLINE FORMS OF FESOTERODINE FUMARATE AND FESOTERODINE BASE

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Forms of rifaximin and uses thereof

Forms of rifaximin and uses thereof

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

Process for producing fingolimod salts

VITAMIN D COMPOUNDS AND METHODS FOR PREPARING SAME

Polymorphs of raltegravir potassium

Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole

Co-crystals of tramadol and coxibs

Methods for the preparation of charged crosslinkers

Crystal modification of Mesotrione

New Crystalline Form of Pemirolast

Method for producing a crystalline solid from glycine-N,N-diacetic acid derivatives with sufficiently reduced hygroscopicity

Process for the preparation of a composition comprising meso-tartaric acid

Zinc oxide complexes

Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

NEW SALTS

2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

Crystals of pyrroloquinolinequinone sodium salts

Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Polymorph Form II of Tanaproget

Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents

CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods

FORMOTEROL TARTRATE PROCESS AND POLYMORPH

PROCESS FOR PREPARING HIGH PURITY 1alpha-HYDROXY VITAMIN D2

Form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and method for producing the same

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

(20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin Din crystalline form

Forms of CDDO methyl ester

Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid

Crystalline salts of a potent HCV inhibitor

Process for the preparation of a powder comprising one or more derivatives of glycine-N,N diacetic acid and/or one or more derivatives of glutamine-N,N diacetic acid and methylglycine-N,N diacetic acid trisodium salt powder

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Novel Compounds

Salts of desvenlafaxine and a method of their preparation

Crystalline forms of genistein

Synthesis of triethylenetetramines

Process for the preparation of histamine H3 receptor modulators

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Delayed release, oral dosage compositions that contain amorphous CDDO-Me

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof

Pharmaceutical forms, and methods of making and using the same

Crystalline polymorphic forms of an antidiabetic compound

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Method for the preparation of cinacalcet and intermediates and impurities thereof

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

BENZIMIDAZOLE COMPOUND CRYSTAL

Polymorphs of Suberoylanilide Hydroxamic Acid

Crystalline form of γ-aminobutyric acid analog

SALT OF NAPHTHYRIDINE CARBOXYLIC ACID DERIVATIVE

PROCESSES FOR PREPARING CINACALCET HYDROCHLORIDE AND POLYMORPHIC FORMS THEREOF

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride

11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Choline cocrystal of epalrestat

POLYMORPHIC FORM OF RASAGILINE MESYLATE

Crystalline vorinostat form VI

Cocrystallization

Crystalline ingenol mebutate

CO-CRYSTALS OF TRAMADOL AND NSAIDs

HCI POLYMORPHS OF 3-((2-(DIMETHYLAMINO)METHYL (CYCLOHEX-1-YL))PHENOL

Nucleoside phosphoramidates

Polymorphs and salts

Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate

Crystal forms of O-desmethylvenlafaxine fumarate

Organic compounds

Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

Polymorph form II of tanaproget

Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]phenyl} carbonyl)cyclohexane-1,3-dione

Process for the preparation of vitamin K2

Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile

Process for producing triphenylene compound and crystal obtained by the process

Compositions for modulating a kinase cascade and methods of use thereof

Fatty acid amide hydrolase inhibitors

Crystal form of calcium 3-acetylaminopropane-1-sulfonate

Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)

Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative

O-DESMETHYLVENLAFAXINE SUCCINATE POLYMORPH & PROCESS FOR PREPARING THEREOF

POLYMORPHIC FORM OF CALCIUM ACAMPROSATE

Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof

CRYSTAL FORMS OF ASTAXANTHIN

Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt

SALTS OF TRAMADOL AND IBUPROFEN AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN

Polymorphic forms α, β and γ of rifaximin

Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt

Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts

Stable dosage forms of levomilnacipran

ANTIBIOTIC COMPOUNDS

Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide

Crystalline forms of an antiviral benzimidazole compound

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol

SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS

Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide

NOVEL PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS

Levodopa prodrug mesylate, compositions thereof, and uses thereof

Crystalline forms of tigecycline hydrochloride

Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs